{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:13:39Z","timestamp":1789665219182,"version":"4.0.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.drudis.2024.104023","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:40:00Z","timestamp":1715614800000},"page":"104023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Lotte J.F.","family":"Van Den Heuvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephina A.N.","family":"Meester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Coucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-9518","authenticated-orcid":false,"given":"Bart L.","family":"Loeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104023_b0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.drudis.2024.104023_b0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2024.104023_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrcardio.2016.211","article-title":"Aetiology and management of hereditary aortopathy","volume":"14","author":"Verstraeten","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.drudis.2024.104023_b0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drudis.2014.09.022","article-title":"Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?","volume":"20","author":"Loeys","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.104023_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.hco.0000139723.49937.43","article-title":"Timing of aortic surgery in the Marfan syndrome","volume":"19","author":"Braverman","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.drudis.2024.104023_b0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000560","article-title":"The Effect of a nonpeptide angiotensin II Type 2 receptor agonist, compound 21, on aortic aneurysm growth in a mouse model of marfan syndrome","volume":"71","author":"Verbrugghe","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.drudis.2024.104023_b0035","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0140-6736(22)01534-3","article-title":"Angiotensin receptor blockers and \u03b2 blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials","volume":"400","author":"Pitcher","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2024.104023_b0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.gim.2021.12.015","article-title":"Molecular characterization and investigation of the role of genetic variation in phenotypic variability and response to treatment in a large pediatric Marfan syndrome cohort","volume":"24","author":"Meester","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.drudis.2024.104023_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4822","article-title":"Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome","volume":"11","author":"Habashi","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2024.104023_b0050","first-page":"e78","article-title":"Aortic aneurysms and dissections series: part II: dynamic signaling responses in aortic aneurysms and dissections","volume":"40","author":"Shen","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.drudis.2024.104023_b0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.drudis.2024.104023_b0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.preghy.2020.01.011","article-title":"The flipside of hydralazine in pregnancy: a systematic review and meta-analysis","volume":"19","author":"Antza","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.drudis.2024.104023_b0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGF\u03b2 signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.drudis.2024.104023_b0070","doi-asserted-by":"crossref","first-page":"35444","DOI":"10.1038\/srep35444","article-title":"Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104023_b0075","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1476-5381.2009.00443.x","article-title":"Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome","volume":"158","author":"Yang","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2024.104023_b0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cjco.2020.12.018","article-title":"Aortic dimensions, biophysical properties, and plasma biomarkers in children and adults with marfan or loeys-dietz syndrome","volume":"3","author":"Cui","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.drudis.2024.104023_b0085","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2024.104023_b0090","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","article-title":"MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome","volume":"110","author":"Xiong","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2024.104023_b0095","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1038\/s41598-020-64071-8","article-title":"Characterization of doxycycline-mediated inhibition of Marfan syndrome-associated aortic dilation by multiphoton microscopy","volume":"10","author":"Tehrani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104023_b0100","first-page":"e14966","article-title":"Doxycycline therapy for abdominal aortic aneurysm: inhibitory effect on matrix metalloproteinases","volume":"13","author":"Paghdar","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.drudis.2024.104023_b0105","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1001\/jama.2020.5230","article-title":"Effect of doxycycline on aneurysm growth among patients with small infrarenal abdominal aortic aneurysms: a randomized clinical trial","volume":"323","author":"Baxter","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2024.104023_b0110","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.120.051171","article-title":"Extracellular tuning of mitochondrial respiration leads to aortic aneurysm","volume":"143","author":"Oller","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2024.104023_b0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00059-019-4786-7","article-title":"Inflammation in thoracic aortic aneurysms","volume":"44","author":"Dinesh","year":"2019","journal-title":"Herz"},{"key":"10.1016\/j.drudis.2024.104023_b0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1067\/mva.2002.123680","article-title":"A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall","volume":"36","author":"Nagashima","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.drudis.2024.104023_b0125","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.121.320381","article-title":"Inhibition of IL11 signaling reduces aortic pathology in murine marfan syndrome","volume":"130","author":"Lim","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2024.104023_b0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12945\/j.aorta.2013.13.007","article-title":"Indomethacin prevents the progression of thoracic aortic aneurysm in marfan syndrome mice","volume":"1","author":"Guo","year":"2013","journal-title":"Aorta (Stamford)"},{"key":"10.1016\/j.drudis.2024.104023_b0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001647","article-title":"Associations of age and sex with marfan phenotype: the National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) registry","volume":"10","author":"Roman","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.drudis.2024.104023_b0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.athoracsur.2021.03.100","article-title":"Sex-based aortic dissection outcomes from the international registry of acute aortic dissection","volume":"113","author":"Huckaby","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.drudis.2024.104023_b0145","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cjca.2023.07.020","article-title":"High-fat diet has a protective sex-dependent effect on aortic aneurysm severity in a marfan syndrome mouse model","volume":"39","author":"Lau","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.drudis.2024.104023_b0150","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/icvts\/ivab270","article-title":"Male\u2013female differences in acute thoracic aortic dissection: a systematic review and meta-analysis","volume":"34","author":"Meccanici","year":"2021","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.drudis.2024.104023_b0155","doi-asserted-by":"crossref","first-page":"e0181166","DOI":"10.1371\/journal.pone.0181166","article-title":"Sex, pregnancy and aortic disease in Marfan syndrome","volume":"12","author":"Renard","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104023_b0160","doi-asserted-by":"crossref","first-page":"e015773","DOI":"10.1161\/JAHA.119.015773","article-title":"Androgens accentuate TGF-\u03b2 dependent Erk\/Smad activation during thoracic aortic aneurysm formation in marfan syndrome male mice","volume":"9","author":"Tashima","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.drudis.2024.104023_b0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.niox.2021.08.006","article-title":"Nitric oxide in the Marfan vasculature: friend or foe?","volume":"116","author":"Tehrani","year":"2021","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.drudis.2024.104023_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/760694","article-title":"Analysis of oxidative stress enzymes and structural and functional proteins on human aortic tissue from different aortopathies","volume":"2014","author":"Soto","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.drudis.2024.104023_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5392454","article-title":"Oxidant\/antioxidant profile in the thoracic aneurysm of patients with the loeys-dietz syndrome","volume":"2020","author":"Soto","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.drudis.2024.104023_b0180","doi-asserted-by":"crossref","first-page":"C977","DOI":"10.1152\/ajpcell.00377.2009","article-title":"Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells","volume":"299","author":"Mariko","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.drudis.2024.104023_b0185","article-title":"Induction of macrophage chemotaxis by aortic extracts from patients with Marfan syndrome is related to elastin binding protein","volume":"6","author":"Guo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104023_b0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.4266","article-title":"Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome","volume":"23","author":"Oller","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2024.104023_b0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s44321-023-00009-7","article-title":"Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation","volume":"16","author":"Ruiz-Rodr\u00edguez","year":"2024","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2024.104023_b0200","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1038\/s41598-022-13772-3","article-title":"Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects","volume":"12","author":"Tehrani","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104023_b0205","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0707181","article-title":"Endothelial dysfunction and compromised eNOS\/Akt signaling in the thoracic aorta during the progression of Marfan syndrome","volume":"150","author":"Chung","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2024.104023_b0210","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","article-title":"Inhibition of Marfan syndrome aortic root dilation by losartan: role of angiotensin II receptor type 1\u2013independent activation of endothelial function","volume":"188","author":"Sellers","year":"2018","journal-title":"Am J Pathology"},{"key":"10.1016\/j.drudis.2024.104023_b0215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.4266","article-title":"Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome","volume":"23","author":"Oller","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2024.104023_b0220","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/s41467-021-22933-3","article-title":"Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO","volume":"12","author":"de la Fuente-Alonso","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104023_b0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/japplphysiol.00132.2017","article-title":"Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm","volume":"123","author":"Gibson","year":"2017","journal-title":"J App Physiol"},{"key":"10.1016\/j.drudis.2024.104023_b0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vph.2009.10.005","article-title":"Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress","volume":"52","author":"Yang","year":"2010","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.drudis.2024.104023_b0235","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ajpath.2019.05.003","article-title":"Sildenafil prevents Marfan-associated emphysema and early pulmonary artery dilation in mice","volume":"189","author":"White","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.drudis.2024.104023_b0240","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1038\/s41467-019-11389-1","article-title":"Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B(12) analog","volume":"10","author":"Schwaerzer","year":"2019","journal-title":"Nat Commun"},{"issue":"Suppl 2","key":"10.1016\/j.drudis.2024.104023_b0245","article-title":"The effect of resveratrol on aortic growth and function in patients with marfan syndrome","volume":"44","author":"Bosshardt","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.drudis.2024.104023_b0250","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/ATVBAHA.116.307841","article-title":"Resveratrol inhibits aortic root dilatation in the Fbn1C1039G\/+ Marfan mouse model","volume":"36","author":"Hibender","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.drudis.2024.104023_b0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2018.02.023","article-title":"Redox stress in Marfan syndrome: dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm","volume":"118","author":"Jim\u00e9nez-Altay\u00f3","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2024.104023_b0260","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jvs.2018.05.246","article-title":"Rapamycin prevents thoracic aortic aneurysm and dissection in mice","volume":"69","author":"Zhou","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.drudis.2024.104023_b0265","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijcard.2010.04.077","article-title":"Evidence for oxidative stress in plasma of patients with Marfan syndrome","volume":"145","author":"Fiorillo","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.drudis.2024.104023_b0270","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.freeradbiomed.2022.11.001","article-title":"Allopurinol blocks aortic aneurysm in a mouse model of Marfan syndrome via reducing aortic oxidative stress","volume":"193","author":"Rodr\u00edguez-Rovira","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2024.104023_b0275","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/biomedicines9091171","article-title":"Oxidative stress-related susceptibility to aneurysm in Marfan's syndrome","volume":"9","author":"Rysz","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2024.104023_b0280","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/ijms21093341","article-title":"Therapeutic effect of rapamycin on aortic dissection in mice","volume":"21","author":"Hayashi-Hori","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104023_b0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000526624","article-title":"Effects of rapamycin on the expression of redox enzymes in aortic vascular smooth muscle cells from Marfan syndrome mice","volume":"107","author":"Mathies","year":"2022","journal-title":"Pharmacology"},{"key":"10.1016\/j.drudis.2024.104023_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115280","article-title":"Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome","volume":"205","author":"Zaradzki","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2024.104023_b0295","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1111\/jcmm.14587","article-title":"Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation","volume":"23","author":"Emrich","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.drudis.2024.104023_b0300","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","article-title":"Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages","volume":"23","author":"Luan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.drudis.2024.104023_b0305","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008543","article-title":"Statins reduce thoracic aortic aneurysm growth in Marfan syndrome mice via inhibition of the ras-induced ERK (extracellular signal-regulated kinase) signaling pathway","volume":"7","author":"Sato","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.drudis.2024.104023_b0310","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1161\/CIRCULATIONAHA.110.012187","article-title":"Pravastatin reduces Marfan aortic dilation","volume":"124","author":"McLoughlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2024.104023_b0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCULATIONAHA.110.985150","article-title":"Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling","volume":"124","author":"Antoniades","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2024.104023_b0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells","volume":"23","author":"Dichtl","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.drudis.2024.104023_b0325","doi-asserted-by":"crossref","first-page":"e127652","DOI":"10.1172\/jci.insight.127652","article-title":"Systems pharmacology-based integration of human and mouse data for drug repurposing to treat thoracic aneurysms","volume":"4","author":"Hansen","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.drudis.2024.104023_b0330","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41467-018-03394-7","article-title":"An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm","volume":"9","author":"Lino Cardenas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104023_b0335","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cvr\/cvq291","article-title":"Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms","volume":"89","author":"Gomez","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.drudis.2024.104023_b0340","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.113.301989","article-title":"Modifications of chromatin dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells","volume":"113","author":"Gomez","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2024.104023_b0345","doi-asserted-by":"crossref","first-page":"e97493","DOI":"10.1172\/jci.insight.97493","article-title":"Inhibition of the methyltranferase EZH2 improves aortic performance in experimental thoracic aortic aneurysm","volume":"3","author":"Lino Cardenas","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.drudis.2024.104023_b0350","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.3390\/ijms21186886","article-title":"Specific miRNA and gene deregulation characterize the increased angiogenic remodeling of thoracic aneurysmatic aortopathy in Marfan syndrome","volume":"21","author":"D'Amico","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104023_b0355","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.111.253740","article-title":"miR-29b Participates in early aneurysm development in Marfan syndrome","volume":"110","author":"Merk","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2024.104023_b0360","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00018-022-04337-8","article-title":"Fibrillin-1-regulated miR-122 has a critical role in thoracic aortic aneurysm formation","volume":"79","author":"Zhang","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2024.104023_b0365","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.ymthe.2018.08.007","article-title":"Correction of the Marfan syndrome pathogenic FBN1 mutation by base editing in human cells and heterozygous embryos","volume":"26","author":"Zeng","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.drudis.2024.104023_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101163","article-title":"Regnase-1 overexpression as a therapeutic approach of Marfan syndrome","volume":"32","author":"Noormalal","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.drudis.2024.104023_b0375","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cvr\/cvab012","article-title":"AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of Marfan syndrome","volume":"117","author":"Remes","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.drudis.2024.104023_b0380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omtn.2017.08.014","article-title":"AP-1 Oligodeoxynucleotides reduce aortic elastolysis in a murine model of Marfan syndrome","volume":"9","author":"Arif","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.drudis.2024.104023_b0385","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1161\/ATVBAHA.121.316496","article-title":"Anti-TGF\u03b2 (Transforming Growth Factor \u03b2) therapy with betaglycan-derived P144 peptide gene delivery prevents the formation of aortic aneurysm in a mouse model of Marfan syndrome","volume":"41","author":"Arce","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 2","key":"10.1016\/j.drudis.2024.104023_b0390","article-title":"Targeted overexpression of regnase-1 in the aorta prevents aneurysm growth in a murine model of Marfan syndrome","volume":"43","author":"Noormalal","year":"2022","journal-title":"Eur Heart J."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462400148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462400148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T19:32:53Z","timestamp":1720121573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462400148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S135964462400148X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104023","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104023"}}